Confronting the epidemic of hepatitis B and C

Mark A. Feitelson, Mark A Zern

Research output: Contribution to journalArticle

Abstract

With 350 million people designated as carriers of hepatitis B, and 170 million chronically infected with hepatitis C, new treatments are urgently needed.

Original languageEnglish (US)
Pages (from-to)140-144
Number of pages5
JournalChemistry and Industry (London)
Issue number4
StatePublished - 1999
Externally publishedYes

Fingerprint

Hepatitis C
Hepatitis B

ASJC Scopus subject areas

  • Chemistry (miscellaneous)

Cite this

Feitelson, M. A., & Zern, M. A. (1999). Confronting the epidemic of hepatitis B and C. Chemistry and Industry (London), (4), 140-144.

Confronting the epidemic of hepatitis B and C. / Feitelson, Mark A.; Zern, Mark A.

In: Chemistry and Industry (London), No. 4, 1999, p. 140-144.

Research output: Contribution to journalArticle

Feitelson, MA & Zern, MA 1999, 'Confronting the epidemic of hepatitis B and C', Chemistry and Industry (London), no. 4, pp. 140-144.
Feitelson, Mark A. ; Zern, Mark A. / Confronting the epidemic of hepatitis B and C. In: Chemistry and Industry (London). 1999 ; No. 4. pp. 140-144.
@article{34987d97cbc047b88f41bdbd791b1a4d,
title = "Confronting the epidemic of hepatitis B and C",
abstract = "With 350 million people designated as carriers of hepatitis B, and 170 million chronically infected with hepatitis C, new treatments are urgently needed.",
author = "Feitelson, {Mark A.} and Zern, {Mark A}",
year = "1999",
language = "English (US)",
pages = "140--144",
journal = "Chemistry and Industry",
issn = "0009-3068",
publisher = "Society of Chemical Industry",
number = "4",

}

TY - JOUR

T1 - Confronting the epidemic of hepatitis B and C

AU - Feitelson, Mark A.

AU - Zern, Mark A

PY - 1999

Y1 - 1999

N2 - With 350 million people designated as carriers of hepatitis B, and 170 million chronically infected with hepatitis C, new treatments are urgently needed.

AB - With 350 million people designated as carriers of hepatitis B, and 170 million chronically infected with hepatitis C, new treatments are urgently needed.

UR - http://www.scopus.com/inward/record.url?scp=0043227942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0043227942&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0043227942

SP - 140

EP - 144

JO - Chemistry and Industry

JF - Chemistry and Industry

SN - 0009-3068

IS - 4

ER -